Biolife Solutions Profit Margin

Biolife Solutions posts a profit margin of 49.06% as of June 2026. That compares with -7.23% in the prior-year period — up 778.8% year over year. That is above the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Biolife Solutions's profit margin was -7.23%. The latest reading is 49.06% — a 778.8% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. Biolife Solutions's 49.06% is higher that level. That is roughly 253.1% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Biolife Solutions's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 49.06% as of June 2026; use YoY and peer views to separate noise from signal.

Context for BLFS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Biolife Solutions's other metric pages and overview cover the third.